Enhanced tumor detection using a folate receptor-targeted near-infrared fluorochrome conjugate

Bioconjugate Chemistry

Volumn 14, Issue 3, 2003, Pages 539-545

  Moon, Woo Kyung ^b   Lin, Yuhui ^c   O'Loughlin, Terence ^c   Tang, Yi ^c   Kim, Dong Eog ^c   Weissleder, Ralph ^c   Tung, Ching Hsuan ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b Seoul National University Biomedical Research Institute   (South Korea)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORESCENCE IMAGING; INFRARED DEVICES; MOLECULAR IMAGING; PROBES; THERMOGRAPHY (IMAGING);

FLUORESCENCE OPTICAL IMAGING; FLUOROCHROMES; FOLATE RECEPTOR; FOLATES; IMAGING PROBE; IN-VIVO; NEAR INFRARED; NEAR-INFRARED; OPTICAL IMAGING TECHNOLOGY; TUMOUR DETECTION;

TUMORS;

FLUOROCHROME; FOLATE RECEPTOR; FOLIC ACID; RECEPTOR; RIBOFLAVIN BINDING PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER DIAGNOSIS; CANCER TRANSPLANTATION; FLUORESCENCE; HUMAN; HUMAN CELL; MOUSE; NASOPHARYNX CARCINOMA; NEAR INFRARED SPECTROSCOPY; NONHUMAN; RECEPTOR AFFINITY; SARCOMA CELL; SQUAMOUS CELL CARCINOMA;

ANIMALIA;

EID: 0038585164     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc0340114     Document Type: Article

References (34)

1. Weissleder, R., Tung, C. H., Mahmood, U., and Bogdanov, A. (1999) In vivo imaging of tumors with protease-activated near-infrared fluorescent probes. Nat. Biotech. 17, 375-8.
2. Tung, C. H., Mahmood, U., Bredow, S., and Weissleder, R. (2000) In vivo imaging of proteolytic enzyme activity using a novel molecular reporter. Cancer Res. 60, 4953-4958.
3. Achilefu, S., Dorshow, R. B., Bugaj, J. E., and Rajagopalan, R. (2000) Novel receptor-targeted fluorescent contrast agents for in vivo tumor imaging. Invest Radiol. 35, 479-85.
4. Becker, A., Hessenius, C., Licha, K., Semmler, W., Wiedenmann, B., and Groetzinger, C. (2001) Receptor targeted optical imaging of tumors with near-infrared flurorescent ligands. Nat. Biotech. 19, 327-31.
5. Marten, K., Bremer, C., Khazaie, K., Sameni, M., Sloane, B., and Tung, C. H. et al. (2002) Detection of dysplastic intestinal adenomas using enzyme-sensing molecular beacons in mice. Gastroenterology 122, 406-14.
6. Bremer, C., Tung, C. H., Bogdanov, A., Jr., and Weissleder, R. (2002) Imaging of differential protease expression in breast cancers for detection of aggressive tumor phenotypes. Radiology 222, 814-8.
7. Bremer, C., Bredow, S., Mahmood, U., Weissleder, R., and Tung, C. H. (2001) Optical imaging of matrix metalloproteinase-2 activity in tumors: feasibility study in a mouse model. Radiology 221, 523-9.
8. Bremer, C., Tung, C. H., and Weissleder, R. (2001) In vivo molecular target assessment of matrix metalloproteinase inhibition. Nat Med. 7, 743-8.
9. Weissleder, R., and Ntziachristos, V. (2003) Shedding light onto live molecular targets. Nat Med, 9, 123-8.
10. Lin, Y., Weissleder, R., and Tung, C. H. (2002) Novel nearinfrared cyanine fluorochromes: synthesis, properties, and bioconjugation. Bioconjugate Chem. 13, 605-10.
11. Ross, J. F., Chaudhuri, P. K., and Ratnam, M. (1994) Differential regulation of folate receptor isoforms in normal and malignant tissues in vivo and in established cell lines. Physiologic and clinical implications. Cancer 73, 2432-43.
12. Miotti, S., Bagnoli, M., Ottone, F., Tomassetti, A., Colnaghi, M. I., and Canevari, S. (1997) Simultaneous activity of two different mechanisms of folate transport in ovarian carcinoma cell lines. J. Cell Biochem. 65, 479-91.
13. Toffoli, G., Cernigoi, C., Russo, A., Gallo, A., Bagnoli, M., and Boiocchi, M. (1997) Overexpression of folate binding protein in ovarian cancers. Int. J. Cancer 74, 193-8.
14. Leamon, C. P., DePrince, R. B., and Hendren, R. W. (1999) Folate-mediated drug delivery: effect of alternative conjugation chemistry. J. Drug Target. 7, 157-69.
15. Lu, Y., and Low, P. S. (2002) Folate-mediated delivery of macromolecular anticancer therapeutic agents. Adv. Drug Deliv. Rev. 54, 675-93.
16. Guo, W., Hinkle, G. H., and Lee, R. J. (1999) 99mTc-HYNIC-folate: a novel receptor-based targeted radiopharmaceutical for tumor imaging. J. Nucl. Med. 40, 1563-9.
17. Mathias, C. J., D. Hubers, Low, P. S., and Green, M. A. (2000) Synthesis of [(99m)Tc]DTPA-folate and its evaluation as a folate-receptor-targeted radiopharmaceutical. Bioconjugate Chem. 11, 253-7.
18. Mathias, C. J., Wang, S., Low, P. S., Waters, D. J., and Green, M. A. (1999) Receptor-mediated targeting of 67Gadeferoxamine-folate to folate- receptor-positive human KB tumor xenografts. Nucl. Med. Biol. 26, 23-5.
19. Wang, S., J. Luo, D. A. Lantrip, Waters, D. J., C. J. Mathias, and Green, M. A. et al. (1997) Design and synthesis of [111In]DTPA-folate for use as a tumor-targeted radiopharmaceutical. Bioconjugate Chem. 8, 673-9.
20. Konda, S. D., M. Aref, S. Wang, M. Brechbiel, and E. C. Wiener (2001) Specific targeting of folate-dendrimer MRI contrast agents to the high affinity folate receptor expressed in ovarian tumor xenografts. Magma 12, 104-13.
21. Konda, S. D., S. Wang, M. Brechbiel, and E. C. Wiener (2002) Biodistribution of a 153 Gd-folate dendrimer, generation = 4, in mice with folate-receptor positive and negative ovarian tumor xenografts. Invest. Radiol. 37, 199-204.
22. Tung, C. H., Y. Lin, W. K. Moon, and Weissleder, R. (2002) A receptor-targeted near-infrared fluorescence probe for in vivo tumor imaging. Chembiochem 3, 784-6.
23. Monaco, H. L. (1997) Crystal structure of chicken riboflavinbinding protein. Embo J. 16, 1475-83.
24. Bohm, H. J. (1998) Prediction of binding constants of protein ligands: a fast method for the prioritization of hits obtained from de novo design or 3D database search programs. J. Comput.-Aided Mol. Des. 12, 309-23.
25. Sanner, M. F., Olson, A. J., and Spehner, J. C. (1996) Reduced surface: an efficient way to compute molecular surfaces. Biopolymers 38, 305-20.
26. Merritt, E. A., and Bacon, D. J. (1997) Raster3D: Photorealistic molecular graphics. Methods Enzymol. 277, 505-24.
27. Mahmood, U., Tung, C., Bogdanov, A., and Weissleder, R. (1999) Near-infrared optical imaging system to detect tumor protease activity. Radiology 213, 866-870.
28. Maziarz, K. M., Monaco, H. L., Shen, F., and Ratnam, M. (1999) Complete mapping of divergent amino acids responsible for differential ligand binding of folate receptors alpha and beta. J. Biol. Chem. 274, 11086-91.
29. Weitman, S. D., Lark, R. H., Coney, L. R., Fort, D. W., Frasca, V., and Zurawski, V. R., Jr., et al. (1992) Distribution of the folate receptor GP38 in normal and malignant cell lines and tissues. Cancer Res. 52, 3396-401.
30. Licha, K., Riefke, B., Ntziachristos, V., Becker, A., Chance, B., and Semmler, W. (2000) Hydrophilic cyanine dyes as contrast agents for near-infrared tumor imaging: synthesis, photophysical properties and spectroscopic in vivo characterization. Photochem. Photobiol. 72, 392-8.
31. Ntziachristos, V., Yodh, A. G., Schnall, M., and Chance, B. (2000) Concurrent MRI and diffuse optical tomography of breast after indocyanine green enhancement. Proc. Natl. Acad. Sci. U.S.A. 97, 2767-72.
32. Stepp, H., Sroka, R., and Baumgartner, R. (1998) Fluorescence endoscopy of gastrointestinal diseases: basic principles, techniques, and clinical experience. Endoscopy 30, 379-86.
33. Jiang, H., Iftimia, N. V., Xu, Y., Eggert, J. A., Fajardo, L. L., and Klove, K. L. (2002) Near-infrared optical imaging of the breast with model-based reconstruction. Acad Radiol. 9, 186-94.
34. Ntziachristos, V., Tung, C. H., Bremer, C., and Weissleder, R. (2002) Fluorescence molecular tomography resolves protease activity in vivo. Nat. Med. 8, 757-60.